PL413123A1 - Ecological method for synthesizing silver nanoparticles - Google Patents

Ecological method for synthesizing silver nanoparticles

Info

Publication number
PL413123A1
PL413123A1 PL413123A PL41312315A PL413123A1 PL 413123 A1 PL413123 A1 PL 413123A1 PL 413123 A PL413123 A PL 413123A PL 41312315 A PL41312315 A PL 41312315A PL 413123 A1 PL413123 A1 PL 413123A1
Authority
PL
Poland
Prior art keywords
weight
aqueous
silver nanoparticles
ecological method
concentration
Prior art date
Application number
PL413123A
Other languages
Polish (pl)
Inventor
Helena Teterycz
Patrycja Suchorska-Woźniak
Olga Rac
Marta Fiedot
Original Assignee
Politechnika Wrocławska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Wrocławska filed Critical Politechnika Wrocławska
Priority to PL413123A priority Critical patent/PL413123A1/en
Publication of PL413123A1 publication Critical patent/PL413123A1/en

Links

Landscapes

  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

Przedmiotem wynalazku jest ekologiczny sposób syntezy nanocząstek srebra, które mogą mieć zastosowanie w medycynie, kosmetyce, technikach sensorowych oraz optoelektronice. Sposób polega na tym, że wodny roztwór polimeru zawierającego w swojej strukturze atomy tlenu i azotu, korzystnie poliwinylopirolidon i/lub poli(L-lizynę), o średniej masie cząsteczkowej 1500 do 950000, o stężeniu od 0,001% do 22% wagowych, miesza się z wodnym roztworem rzeczywistym reduktora o stężeniu 0,001% do 10% wagowych i wodnym roztworem rzeczywistym wodorotlenku nieorganicznego o stężeniu 0,001% do 10% wagowych oraz dodaje się wodny roztwór prekursora, zawierającego jony srebrowe o stężeniu wagowym od 0,001% do 10% wagowych.The subject of the invention is an ecological method of synthesis of silver nanoparticles that can be used in medicine, cosmetics, sensor techniques and optoelectronics. The method consists in the fact that an aqueous polymer solution containing in its structure oxygen and nitrogen atoms, preferably polyvinylpyrrolidone and / or poly (L-lysine), with an average molecular weight of 1500 to 950000, at a concentration of 0.001% to 22% by weight, is mixed. with an aqueous real solution of the 0.001% to 10% by weight reducer and an aqueous real solution of inorganic hydroxide at 0.001% to 10% by weight, and an aqueous precursor solution containing silver ions having a concentration of 0.001% to 10% by weight is added.

PL413123A 2015-07-14 2015-07-14 Ecological method for synthesizing silver nanoparticles PL413123A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL413123A PL413123A1 (en) 2015-07-14 2015-07-14 Ecological method for synthesizing silver nanoparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL413123A PL413123A1 (en) 2015-07-14 2015-07-14 Ecological method for synthesizing silver nanoparticles

Publications (1)

Publication Number Publication Date
PL413123A1 true PL413123A1 (en) 2016-08-16

Family

ID=56617387

Family Applications (1)

Application Number Title Priority Date Filing Date
PL413123A PL413123A1 (en) 2015-07-14 2015-07-14 Ecological method for synthesizing silver nanoparticles

Country Status (1)

Country Link
PL (1) PL413123A1 (en)

Similar Documents

Publication Publication Date Title
Goudouri et al. Antibacterial properties of metal and metalloid ions in chronic periodontitis and peri-implantitis therapy
CY1124798T1 (en) SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
GB2529322A (en) Ampholyte polymeric compounds in subterranean applications
PH12015502615A1 (en) Chemical compounds
WO2019240713A3 (en) Solutions comprising ozonized oil
BR112017020952A2 (en) cancer treatment method, composition and use of composition
MX383037B (en) Delivery of surfactant soluble anti-dandruff agent
NZ733174A (en) Quinazoline derivatives used to treat hiv
PH12018500987A1 (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
MY162146A (en) Pharmaceutical composition
PH12015502729A1 (en) Personal care compositions and articles
TN2015000313A1 (en) Chemical compounds
MX2018006918A (en) Liquid polymer compositions.
MX2020010375A (en) NEW DERIVATIVES OF 3'-DESOXYADENOSINE PHOSPHORAMIDATE ESTER OF 2' AND/OR 5' AMINO ACID AS ANTI-CANCER COMPOUNDS.
MX2012013408A (en) Compositions, systems, and/or methods involving chlorine dioxide ("cio2").
MY190687A (en) Antimicrobial compositions and related methods of use
BR112015017843A2 (en) fertilizer composition and method for suspending the fertilizer in an aqueous solution
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
MY171970A (en) Aqueous solutions containing a complexing agent in high concentration
BR112016026042A8 (en) preparation of rocuronium in liquid form and method
MX382596B (en) COMPOSITIONS CONTAINING ARSENIC AND THEIR USE IN TREATMENT METHODS.
MX361642B (en) Cationic antiseptic compositions.
LT2012042A (en) Process for preparing plastics surfaces prior to their chemical metallization
MX2017013049A (en) Pharmaceutical salt forms of an inhibitor of semicarbazide-sensit ive amine oxidase (ssao).
MX2015013122A (en) Modified hyaluronate hydrophilic compositons, coatings and methods.